Futura Medical Company Description

Futura Medical plc research, develops, and sells pharmaceutical and healthcare products for sexual health.

Its lead product is Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women.

The company operates in the United Kingdom, the European Union, the United States, and internationally.

Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

Futura Medical plc

Country	United Kingdom
Founded	2001
Industry	Biotechnology
Sector	Healthcare
Employees	14
CEO	James Barder

Contact Details

Address: Surrey Technology Centre Guildford, GU2 7YG United Kingdom
Phone	44 14 8368 5670
Website	futuramedical.com

Stock Details

Ticker Symbol	FAMDF
Exchange	OTCMKTS
Fiscal Year	January - December
Reporting Currency	GBP
ISIN Number	GB0033278473
SIC Code	2834

Key Executives

Name	Position
James Henry Barder	Chief Executive Officer and Executive Director
Angela Hildreth	Chief Operating Officer, Finance Director, Company Secretary and Executive Director
Kenneth William James	Head of Research & Development and Executive Director
Dr. William Duncan Potter BSc (Hons), MSc, Ph.D.	Chief Scientific Officer and Adviser to the Board
Graham Smith	Head of Alliance Partnerships and Supply
Kevin Langridge	Head of Quality